IL157588A0 - Carbamate compounds for use in preventing or treating psychotic disorders - Google Patents

Carbamate compounds for use in preventing or treating psychotic disorders

Info

Publication number
IL157588A0
IL157588A0 IL15758802A IL15758802A IL157588A0 IL 157588 A0 IL157588 A0 IL 157588A0 IL 15758802 A IL15758802 A IL 15758802A IL 15758802 A IL15758802 A IL 15758802A IL 157588 A0 IL157588 A0 IL 157588A0
Authority
IL
Israel
Prior art keywords
preventing
psychotic disorders
carbamate compounds
treating psychotic
treating
Prior art date
Application number
IL15758802A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL157588A0 publication Critical patent/IL157588A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15758802A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders IL157588A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number Publication Date
IL157588A0 true IL157588A0 (en) 2004-03-28

Family

ID=26765939

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15758802A IL157588A0 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
IL157588A IL157588A (en) 2001-02-27 2003-08-26 Carbamate compounds for use in preventing or treating psychotic disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157588A IL157588A (en) 2001-02-27 2003-08-26 Carbamate compounds for use in preventing or treating psychotic disorders

Country Status (25)

Country Link
US (1) US6541513B2 (cs)
EP (1) EP1401424B1 (cs)
JP (1) JP4276841B2 (cs)
KR (1) KR100886578B1 (cs)
CN (1) CN1262271C (cs)
AR (1) AR032876A1 (cs)
AT (1) ATE346597T1 (cs)
AU (1) AU2002242296B2 (cs)
BR (1) BR0207829A (cs)
CA (1) CA2439480C (cs)
CZ (1) CZ302412B6 (cs)
DE (1) DE60216457T2 (cs)
DK (1) DK1401424T3 (cs)
ES (1) ES2275844T3 (cs)
HU (1) HUP0303342A3 (cs)
IL (2) IL157588A0 (cs)
MX (1) MXPA03007722A (cs)
NO (1) NO20033801L (cs)
NZ (1) NZ527991A (cs)
PL (1) PL365021A1 (cs)
PT (1) PT1401424E (cs)
RS (1) RS51056B (cs)
RU (1) RU2302240C2 (cs)
TW (1) TWI251486B (cs)
WO (1) WO2002067927A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1305082B1 (en) * 2000-07-21 2004-05-26 Ortho-McNeil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
US7078436B2 (en) * 2001-02-27 2006-07-18 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
ATE361745T1 (de) * 2001-02-27 2007-06-15 Ortho Mcneil Pharm Inc Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
JP4362367B2 (ja) 2001-07-16 2009-11-11 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 神経因性疼痛および群発および偏頭痛に伴う疼痛の防止または処置に使用するためのカルバメート化合物
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
BRPI0718323A2 (pt) * 2006-10-31 2013-11-26 Janssen Pharmaceutica Nv Tratamento de transtornos invasivos do desenvolvimento.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2970112B1 (en) * 2013-03-12 2025-03-12 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
DK0480939T3 (da) * 1989-06-09 1995-07-10 Upjohn Co Heterocycliske aminer med virkning på centralnervesystemet
US5492930A (en) 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
EP1401424B1 (en) 2006-11-29
RS51056B (sr) 2010-10-31
JP4276841B2 (ja) 2009-06-10
HUP0303342A2 (hu) 2004-01-28
IL157588A (en) 2009-12-24
BR0207829A (pt) 2004-06-22
RU2003128983A (ru) 2005-03-10
DK1401424T3 (da) 2007-02-26
CA2439480C (en) 2011-04-26
KR20030076713A (ko) 2003-09-26
HUP0303342A3 (en) 2012-07-30
US6541513B2 (en) 2003-04-01
CA2439480A1 (en) 2002-09-06
NZ527991A (en) 2005-04-29
PL365021A1 (en) 2004-12-27
EP1401424A1 (en) 2004-03-31
RU2302240C2 (ru) 2007-07-10
DE60216457D1 (de) 2007-01-11
US20020165272A1 (en) 2002-11-07
CZ302412B6 (cs) 2011-05-04
RS67503A (en) 2006-12-15
ATE346597T1 (de) 2006-12-15
AU2002242296B2 (en) 2006-06-29
TWI251486B (en) 2006-03-21
ES2275844T3 (es) 2007-06-16
PT1401424E (pt) 2007-02-28
AR032876A1 (es) 2003-11-26
CZ20032297A3 (cs) 2004-06-16
NO20033801L (no) 2003-10-22
MXPA03007722A (es) 2004-11-12
NO20033801D0 (no) 2003-08-26
JP2004523556A (ja) 2004-08-05
KR100886578B1 (ko) 2009-03-05
CN1505507A (zh) 2004-06-16
CN1262271C (zh) 2006-07-05
DE60216457T2 (de) 2007-09-20
WO2002067927A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PT2311466E (pt) Compostos antimicrobianos e métodos para a sua utilização
HUP0501116A3 (en) Oxynthomodulin for preventing or treating excess weight
GB0119152D0 (en) Therapeutic agents
GB0112343D0 (en) Well treatment
IL160208A0 (en) Amidine derivatives for treating amyloidosis
IL157592A0 (en) Carbamate compounds for use in preventing or treating movement disorders
IL157591A0 (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368556A1 (en) Methods for treating or preventing skin disorders using cd2-binding agents
HUP0303261A3 (en) Carbamate compounds for use in preventing or treating bipolar disorder
IL157588A0 (en) Carbamate compounds for use in preventing or treating psychotic disorders
HUP0303236A3 (en) Carbamate compounds for use in the treatment of pain
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
GB0108930D0 (en) Therapeutic agents
GB0117060D0 (en) Therapeutic agents
EP1419236A4 (en) METHODS OF TREATING OR PREVENTING SCLEROSIS BY USE OF CD2-BINDING AGENTS
GB0113843D0 (en) Therapeutic agents
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
GB0108982D0 (en) Therapeutic agents
ZA200307477B (en) Carbamate compounds for use in preventing or treating movement disorders.
PL354980A1 (en) Use dexrazoxane for treating psoriasis
HUP0402141A3 (en) Herbicidal composition and process for its use
ZA200307473B (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders.
TWI318876B (en) Carbamate compounds for use in preventing or treating bipolar disorder
GB0130694D0 (en) Treatment